Top Healthcare Market Research Companies in Europe (2026 Guide)

BioNixus is a global market research and insights firm headquartered in Sheridan, Wyoming (USA) with offices in London (UK), combining 15+ years of experience with full-spectrum capability across pharmaceutical, healthcare, and consumer research. For Europe, BioNixus is positioned as the Europe-capable MENA↔EU bridge: pan-European studies that stay comparable across EU5 while localising for EMA, NICE, G-BA/IQWiG, HAS, AIFA, and AEMPS evidence expectations — and that connect cleanly to GCC and wider MENA programmes when regional leadership needs one evidence framework. Capabilities include physician and specialist surveys across major European centres; KOL identification and influence mapping by therapy area; hospital pharmacy and national payer / HTA-adjacent interviews; HEOR and real-world evidence strategy support; and competitive intelligence for launch and lifecycle planning. Multilingual execution and shared instruments keep multi-country synthesis decision-ready rather than fragmented country silos.

IQVIA is the world's largest healthcare data and analytics company, with deep European prescription audit, hospital, and real-world evidence infrastructure. IQVIA's core European value is proprietary data — retail and hospital audits, longitudinal patient panels where available, and commercial analytics that quantify share, switching, and channel mix across EU markets. Primary research capabilities supplement data products for attitudinal and qualitative insights. Best suited for clients needing prescription measurement, RWE platforms, or sales analytics rather than custom qualitative depth, MENA↔EU bridge programmes, or HTA-strategy primary fieldwork.

Kantar supports European pharmaceutical and consumer health clients with brand health tracking, patient perception research, and disease awareness studies. Kantar's primary European strength is established consumer and patient panel infrastructure — making it a strong partner for large-scale quantitative consumer health brand tracking, longitudinal patient panels, and OTC/consumer healthcare research. For prescription pharma, specialist physician research, and HTA/access strategy, Kantar's generalist consumer strengths typically need specialist HCP recruitment and qualitative depth from a healthcare-focused partner.

Ipsos Healthcare operates across Europe within Ipsos's global network, supporting pharmaceutical and consumer health clients with physician attitude-and-usage studies, patient research, disease awareness studies, and advertising concept testing. Ipsos brings methodological rigour, large consumer panel infrastructure, and scale for nationally representative quantitative studies. The Healthcare division provides dedicated pharmaceutical research expertise within the broader Ipsos network; pharma-specific depth and HTA/access qualitative programmes depend on the specialist team assigned.

M3 Global Research provides physician panel access and digital survey capabilities for European healthcare markets, enabling rapid quantitative studies with verified physicians across specialties through online physician communities. M3's model focuses on online physician panels and self-completion surveys rather than in-depth qualitative research, complex multi-country HTA strategy, or MENA↔EU bridge programmes. Best suited for fast-turnaround HCP attitude-and-usage surveys, concept testing, and quantitative market sizing where online physician access is the priority.

Decision Resources Group (now part of Clarivate) provides secondary pharmaceutical and medical device intelligence for European markets, including epidemiology data, treatment algorithm mapping, pipeline tracking, and competitive landscape analysis. Coverage spans oncology, cardiovascular, diabetes, respiratory, immunology, and rare diseases — serving commercial strategy and launch planning teams with data-led secondary context. DRG does not replace custom primary research; its value is proprietary secondary intelligence complementing fieldwork from primary research specialists like BioNixus.

GfK is a long-established European insights network with particular strength in retail measurement, consumer healthcare, and OTC brand tracking. For pharmaceutical prescription research, KOL mapping, and HTA/payer primary studies, GfK is typically less specialised than dedicated healthcare primary research firms. Best suited for consumer health, retail pharmacy channel measurement, and OTC brand strategy rather than specialist HCP qualitative programmes or MENA↔EU bridge studies.